Development of a stable cell manufacturing process based on a novel risk assessment method considering control difficulty
Conference Dates
February 1 – 5, 2026
Abstract
Please click Additional Files below to see the full abstract
Recommended Citation
Masahiro Kino-oka, "Development of a stable cell manufacturing process based on a novel risk assessment method considering control difficulty" in "Advancing Manufacture of Cell and Gene Therapies IX [2026]", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/23
44.pdf (153 kB)
COinS